Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · Real-Time Price · USD
10.59
-0.51 (-4.59%)
Jun 20, 2025, 4:00 PM - Market closed
Anika Therapeutics Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Anika Therapeutics stock has a target of 19, which predicts a 79.41% increase from the current stock price of 10.59.
Price Target: $19 (+79.41%)
Analyst Consensus: Buy
* Price targets were last updated on May 12, 2025.
Analyst Ratings
According to 1 stock analyst, the rating for Anika Therapeutics is "Buy". This means that the analyst believes this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barrington Research | Barrington Research | Buy Maintains $20 → $19 | Buy | Maintains | $20 → $19 | +79.41% | May 12, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $25 → $20 | Buy | Maintains | $25 → $20 | +88.86% | Mar 13, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $37 → $25 | Buy | Maintains | $37 → $25 | +136.07% | Nov 1, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $37 | Buy | Maintains | $37 | +249.39% | Oct 22, 2024 |
| Barrington Research | Barrington Research | Buy Maintains $37 | Buy | Maintains | $37 | +249.39% | Aug 9, 2024 |
Financial Forecast
Revenue This Year
112.16M
from 119.91M
Decreased by -6.46%
Revenue Next Year
123.04M
from 112.16M
Increased by 9.70%
EPS This Year
-1.12
from -3.83
EPS Next Year
-0.22
from -1.12
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 116.0M | 128.6M | 132.8M |
| Avg | 112.2M | 123.0M | 129.0M |
| Low | 107.0M | 114.8M | 123.9M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -3.2% | 14.7% | 7.9% |
| Avg | -6.5% | 9.7% | 4.8% |
| Low | -10.7% | 2.3% | 0.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -1.05 | 0.81 | -0.02 |
| Avg | -1.12 | -0.22 | -0.02 |
| Low | -1.18 | -0.79 | -0.02 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.